熱門資訊> 正文
NRx Pharmaceuticals宣布提供高达1600万美元的高级担保债务融资
2024-08-13 21:03
- NRx Pharmaceuticals (NASDAQ:NRXP) on Tuesday said it has obtained up to about $16 million in convertible debt financing from an institutional investor.
- The company intends to use the net proceeds from the financing to support the 2024 New Drug Application filing its two lead products, NRX-100 and NRX-101 and to retire existing debt from Streeterville Capital.
- Concurrent with this financing, Streeterville has agreed to stay its arbitration and to release all claims upon receipt of the agreed settlement funds.
- NRXP +3.9% premarket to $2.13.
- Source: Press Release
More on NRx Pharmaceuticals
- Seeking Alpha’s Quant Rating on NRx Pharmaceuticals
- Historical earnings data for NRx Pharmaceuticals
- Financial information for NRx Pharmaceuticals
推薦文章
風險及免責提示：以上內容僅代表作者的個人立場和觀點，不代表華盛的任何立場，華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前，應結合自身情況，考慮投資產品的風險。必要時，請諮詢專業投資顧問的意見。華盛不提供任何投資建議，對此亦不做任何承諾和保證。
